The Patent Finder

Wallkill Biopharma, Inc.

Also on record
Records under this name other than the patents Wallkill Biopharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 5 of 5 · Back to Wallkill Biopharma, Inc.

PatentTitleStatus Expires Confidence
US 10,696,950Treating Diabetes with Genetically Modified Beta Cells
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,982,190Genetically Modified Stem Cells
Formerly held
In force
 · Low confidence
In forceLow confidence
US 11,186,827Genetically Modified Stem Cells
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,739,298Genetically Modified Stem Cells
Formerly held
In force
 · Low confidence
In forceLow confidence
US 12,365,876Genetically Modified Stem Cells
Formerly held
In force
 · Low confidence
In forceLow confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited